Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers - Supplemental material
Published: 7 March 2025| Version 1 | DOI: 10.17632/py8x6hzk4b.1
Contributors:
, , , , , Description
Supplementary material for the study "Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers"
Files
Institutions
Quantify Research AB
Categories
Dermatology, Pharmacoepidemiology, Biologicals, Propensity Score, Pharmacovigilance, Biologicals in Rheumatology